Page 3 - Robert Stott News Today

The FDA has granted breakthrough device designation to EndoStim for its implantable device which serves as a treatment option for patients with refractory gastroesophageal reflux disease, according to a manufacturer release. The EndoStim System is a neurostimulation device which is implanted laparoscopically and designed to provide long-term reflux control via automatically delivered mild

The FDA issued a complete response letter to Gilead indicating it cannot approve the company’s new drug application that seeks approval of bulevirtide for chronic hepatitis D virus infection and compensated liver disease. In its letter, the FDA cited concerns over the manufacture and delivery of bulevirtide, a first-in-class investigational entry-inhibitor; however, no new studies to assess

Abivax announced that the first U.S. patient has been enrolled in its global phase 3 clinical trial of its oral small-molecule inhibitor obefazimod for the treatment of moderate to severe ulcerative colitis. The trial will include two induction studies – ABTECT-1 (ABX464-105) and ABTECT-2 (ABX464-106) – and a subsequent ABTECT maintenance trial (ABX464-107) that will investigate 25

LONDON — Cirrhosis severity, infections and mortality outcomes were worse for patients in low to middle-income countries, due in part to poor access to liver transplant and ICU facilities, according to data presented here. “We have health care disparities as well as differing populations and diseases that cause cirrhosis around the world,” Jasmohan S. Bajaj, MD, associate

LONDON — A low-carbohydrate, high-fat diet significantly improved nonalcoholic fatty liver disease activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with type 2 diabetes mellitus, according to a researcher here.

LONDON —WHO presented updated guidance on hepatitis C, calling for drastic simplification of care pathways to alleviate access gaps in HCV testing and treatment, during a joint WHO-EASL-CDC symposium at the International Liver Congress. “In 2016, when WHO launched its global strategy, there were ambitious plans for elimination, defined as a 90% reduction in incidence and a 65%

A former gang member from Los Angeles who shot and killed a postal worker in Utah and then shot at others who tried to help the victim is seeking parole after 25 years.

MIAMI — Incorporating clinical trials into daily practice can both enhance patient treatment options and provide a stream of reimbursement revenue to support the practice, according to a presenter at the Scrubs and Heels Summit. “In my practice, I always ask myself, no matter where a patient is in the course of disease: Would this patient potentially benefit from inclusion in a

MIAMI – Female gastroenterologists continue to be underrepresented in leadership positions and earn less than their male counterparts, spotlighting a critical ally role for males, noted a presenter at Scrubs and Heels Summit.Despite some progress in the field, gender gaps persist in pay and promotions – and not for lack of female presence in the pipeline.

Although the rate of surgery for inflammatory bowel disease has declined significantly in the era of biologic therapy, “it is still occurring,” according to a presenter at the Crohn’s and Colitis Congress. “If you think in terms of risk, about what the most disabling situation is when it comes to ulcerative colitis, it’s probably surgery, and most patients would like